Busulfex
information and resources from the National Cancer Institute
NCI Thesaurus | Busulfex
(Other name for: busulfan)NCI Thesaurus | Busulfex
(Other name for: busulfan)
busulfan intravenous
Use in combination with cyclophoshamide as conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia.
Orphan Medical, Inc Feb 04 1999
|
|
|
|
news articles
PDL BioPharma Announces Fourth Quarter and Full Year 2005 ... Feb 27, 2006
PharmaLive.com (press release), ...growing commercial presence in the acute-care hospital market with three proprietary marketed products in Cardene(R) IV, Retavase(R) and IV Busulfex(R)," said ...
PDL BioPharma Announces Fourth Quarter and Full Year 2005 ... Feb 27, 2006
Yahoo! News (press release) ...commercial presence in the acute-care hospital market with three proprietary marketed products in Cardene® IV, Retavase® and IV Busulfex®," said Mark McDade ...
PDL's Potent Pick-Me-Up Feb 27, 2006
BusinessWeek IV Busulfex is approved as a conditioning agent to be used in combination with cyclophosphamide prior to blood or marrow transplant in patients with chronic ...
Dr. Joy L. Frestedt named Vice President of Clinical Affairs for ... Dec 13, 2005
Genetic Engineering News, ...at the Mayo Clinic in Rochester, Minnesota; Medical Information Scientist for Astra Zeneca Pharmaceuticals; and Manager of Busulfex Clinical Development for ...
|
|
